

Struggling to find Mercaptopurine at your pharmacy? Learn why this essential leukemia and IBD medication is so hard to find in 2026 and what you can do.
If you or a loved one depends on Mercaptopurine — whether for leukemia treatment or managing an autoimmune condition — you may have run into a frustrating problem: your pharmacy doesn't have it in stock. You call around, check different locations, and keep hearing the same thing: "We're out, and we don't know when it's coming back."
You're not imagining it. Mercaptopurine (also known as 6-MP, Purinethol, or Purixan) has been increasingly difficult to find since late 2023, and the shortage has continued into 2026. Here's what's going on — and what you can do about it.
Mercaptopurine is an oral chemotherapy medication classified as a purine antagonist (antimetabolite). It's FDA-approved for treating acute lymphoblastic leukemia (ALL) in children and adults as part of maintenance chemotherapy. It works by interfering with DNA and RNA synthesis in rapidly dividing cells, slowing the growth of cancer cells.
Beyond cancer, Mercaptopurine is widely prescribed off-label for inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, as well as autoimmune hepatitis and other immune-related conditions. For many patients, it's a critical part of long-term disease management.
There isn't one single reason Mercaptopurine is hard to find — it's a combination of factors that have created a perfect storm of limited supply.
Several manufacturers that produce generic Mercaptopurine 50 mg tablets have experienced production issues. Most notably, Quinn Pharmaceuticals temporarily discontinued its Mercaptopurine 50 mg tablets (both 25-count and 250-count bottles) with no estimated release date. When one manufacturer drops out, the remaining companies can't always ramp up production fast enough to fill the gap.
Unlike blockbuster drugs with dozens of generic manufacturers, Mercaptopurine is produced by a relatively small number of companies. This makes the supply chain fragile — when even one or two manufacturers have problems, patients feel the effects immediately.
The active pharmaceutical ingredients (APIs) used to make Mercaptopurine come from a limited number of global suppliers. Disruptions in raw material availability — whether due to regulatory issues, quality concerns, or logistics — can slow or halt production.
Even when supply exists, wholesalers and distributors sometimes place allocation limits on how much any single pharmacy can order. This means your local pharmacy may only be able to get a handful of bottles at a time, leading to constant stock-outs even when the drug isn't completely unavailable nationally.
The shortage is real, but there are steps you can take to improve your chances of getting your medication:
Tools like Medfinder can help you check which pharmacies near you currently have Mercaptopurine in stock. Instead of calling pharmacy after pharmacy, you can search in one place and save hours of frustration.
Chain pharmacies tend to get hit hardest by shortages because they rely on centralized distribution. Independent pharmacies often have different wholesale relationships and may have stock when larger chains don't. Specialty pharmacies that serve oncology patients may also carry Mercaptopurine more reliably.
If you can't find the 50 mg tablets, ask your doctor about Purixan, the brand-name oral suspension (20 mg/mL). While it's more expensive, it may be available when tablets aren't — and it's especially useful for patients who need precise dosing, such as children.
If Mercaptopurine remains unavailable, your doctor may be able to consider alternatives such as Azathioprine, Methotrexate, or Thioguanine, depending on your condition and treatment protocol.
If you're currently on Mercaptopurine, don't wait until you're out of pills to request a refill. Talk to your pharmacy and prescriber about filling prescriptions early when possible, and keeping a buffer supply during shortage periods.
Missing doses of Mercaptopurine can have serious consequences — for cancer patients, it can affect treatment outcomes, and for IBD patients, it can trigger disease flares. The shortage is frustrating, but understanding why it's happening and knowing your options can help you stay ahead of it.
If you're struggling to find Mercaptopurine right now, Medfinder can help you locate pharmacies with stock near you. You can also read our Mercaptopurine shortage update for 2026 for the latest information on supply and availability.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.